Literature DB >> 7544245

Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor V beta 2 gene usage in microscopic polyarteritis.

I J Simpson1, M A Skinner, A Geursen, J S Peake, W G Abbott, J D Fraser, C M Lockwood, P L Tan.   

Abstract

Antigen recognition by T lymphocytes is mediated by cell surface receptors T cell specificity depends on the variable, diversity and junctional (VDJ) regions of the alpha and beta polypeptide chains of the T cell receptor (TCR). The expression of the variable region genes of the beta chain (V beta) has been analysed to study the involvement of peripheral blood T cells in systemic vasculitis. RNA was extracted from peripheral blood lymphocytes of 12 patients with microscopic polyarteritis, 10 with Wegener's granulomatosis, six with unclassified vasculitis, and 28 healthy age- and sex-matched individuals. Complementary DNA was made from RNA and amplified by the anchored polymerase chain reaction (PCR) using redundant oligonucleotide primers for the TCR V beta genes. To determine if the dominant usage of a V beta gene family reflected the presence of particular T cell clones, cDNA was amplified with primers for the specific V beta gene family. The product was screened for sequence homogeneity by single-stranded conformational polymorphism (SSCP) and cloned to sequence the adjoining TCR (D beta) J beta region. A significant increase in the mean percentage expression of the V beta 2.1 gene was seen in vasculitis patients (11.4 + 1.0% (mean + s.e.m.)) compared with controls (6.6 + 0.6%; P < 0.003). The most marked increase was seen in microscopic polyarteritis (13.9 + 1.7%; P < 0.0001). There were also increases in the expression of V beta 3, 13 and 14 in peripheral blood of vasculitis patients compared with controls. SSCP analysis of V beta 2.1 amplified products indicated the presence of oligoclonal bands in a smaller proportion of patients (8/27) than controls (12/28). There was no strong evidence for the conservation of the TCR V beta 2.1 junctional region sequence data from a sample group of three patients with oligoclonal bands. Thus, a subset of patients with systemic vasculitis, particularly those with microscopic polyarteritis, have increased TCR V beta 2.1 gene expression in their peripheral blood T cell repertoire. As superantigens binding V beta 2.1 are postulated to activate T cells with diverse CDR3 sequences, it is proposed that a superantigen is involved in the immunopathogenesis of vasculitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544245      PMCID: PMC1553271          DOI: 10.1111/j.1365-2249.1995.tb08342.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis.

Authors:  J T Lie
Journal:  Pathol Annu       Date:  1989

2.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

Review 3.  Genes of the T-cell antigen receptor in normal and malignant T cells.

Authors:  B Toyonaga; T W Mak
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

4.  Therapy of vasculitis.

Authors:  P A Bacon
Journal:  J Rheumatol       Date:  1994-05       Impact factor: 4.666

5.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

Authors:  D J Davies; J E Moran; J F Niall; G B Ryan
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

6.  Microscopic polyarteritis: presentation, pathology and prognosis.

Authors:  C O Savage; C G Winearls; D J Evans; A J Rees; C M Lockwood
Journal:  Q J Med       Date:  1985-08

7.  TCR V beta family repertoire and T cell activation markers in Kawasaki disease.

Authors:  B A Pietra; J De Inocencio; E H Giannini; R Hirsch
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

8.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

9.  Distribution of MHC class II alleles in primary systemic vasculitis.

Authors:  L Zhang; D R Jayne; M H Zhao; C M Lockwood; D B Oliveira
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

10.  Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.

Authors:  Y Choi; J A Lafferty; J R Clements; J K Todd; E W Gelfand; J Kappler; P Marrack; B L Kotzin
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Pathogenesis and treatment of ANCA-associated systemic vasculitis.

Authors:  A D Salama
Journal:  J R Soc Med       Date:  1999-09       Impact factor: 5.344

Review 2.  Cellular aspects of vasculitis--T cell-mediated aspects.

Authors:  M E Griffith; C D Pusey
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  Lipid-derived free radical production in superantigen-induced interstitial pneumonia.

Authors:  Hisako Miyakawa; Ronald P Mason; Jinjie Jiang; Maria B Kadiiska
Journal:  Free Radic Biol Med       Date:  2009-04-17       Impact factor: 7.376

5.  Analysis of T-cell receptor usage in myeloperoxidase--antineutrophil cytoplasmic antibody-associated renal vasculitis.

Authors:  Kouichi Hirayama; Takashi Ishizu; Homare Shimohata; Yasunori Miyamoto; Tomoko Kakita; Miho Nagai; Yujiro Ogawa; Shogo Fujita; Aki Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2009-10-07       Impact factor: 2.801

6.  Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Milorad Pavlovic; Zoran Dimcic; Branislava Ivanovic; Milos Nikolic
Journal:  Clin Rheumatol       Date:  2010-03-20       Impact factor: 2.980

7.  T cell Vbeta repertoires in childhood vasculitides.

Authors:  P A Brogan; V Shah; A Bagga; N Klein; M J Dillon
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

8.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis.

Authors:  A R Clayton; C O S Savage
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.